These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 4429105)
1. Comparison of prostaglandin F2alpha and hypertonic saline for induction of midtrimester abortion. Lauersen NH; Wilson KH; Beling CG; Fuchs F Am J Obstet Gynecol; 1974 Dec; 120(7):875-9. PubMed ID: 4429105 [TBL] [Abstract][Full Text] [Related]
2. Midtrimester intra-aminotic administration of prostaglandin F2alpha in combination with an hyperosmolar urea solution: effect upon plasma levels of estradiol, progesterone, and human placental lactogen (HPL). Sher G; Katz M Acta Obstet Gynecol Scand; 1978; 57(3):223-5. PubMed ID: 665164 [TBL] [Abstract][Full Text] [Related]
3. Midtrimester pregnancy interruption and the placental progesterone levels. Aleem FA; Schulman H Prostaglandins; 1975 Mar; 9(3):495-500. PubMed ID: 1138306 [TBL] [Abstract][Full Text] [Related]
4. Induction of therapeutic abortion using either extra-amniotic prostaglandin F-2-alpha or hypertonic saline followed by oxytocin. Lange AP; Secher NJ; Pedersen GT Prostaglandins; 1974 Apr; 6(2):149-57. PubMed ID: 4847514 [TBL] [Abstract][Full Text] [Related]
5. Second-trimester termination with 16,16 dimethyl-PGE1-methyl ester (gemeprost), compared with a regimen that included intra-amniotic PGF2 alpha and hypertonic saline. Waldron KW; Renou PM; Lolatgis N; Morris ND; Mamers PM; Oldham J; Healy DL Reprod Fertil Dev; 1990; 2(5):495-8. PubMed ID: 2075246 [TBL] [Abstract][Full Text] [Related]
6. Continuous extraovular administration of prostaglandin F2alpha for midtrimester abortion. Lauersen NH; Wilson KH Am J Obstet Gynecol; 1974 Sep; 120(2):273-80. PubMed ID: 4412615 [TBL] [Abstract][Full Text] [Related]
7. The induction of midtrimester abortion with intra-amniotic prostaglandin F2alpha. A single-dose technique. Corlett RC; Ballard CA Am J Obstet Gynecol; 1974 Feb; 118(3):353-7. PubMed ID: 4810039 [TBL] [Abstract][Full Text] [Related]
8. Mid-trimester abortion with intra-amniotic prostaglandin F2 alpha and intravenous oxytocin infusion. Salomy M; Halbrecht I; London R Prostaglandins; 1975 Feb; 9(2):271-9. PubMed ID: 1135439 [TBL] [Abstract][Full Text] [Related]
9. Use of prostaglandin, hypertonic saline and oxytocin for second-trimester abortion. Muzsnai D; Kerenyi T Eur J Obstet Gynecol Reprod Biol; 1979 Dec; 9(6):385-9. PubMed ID: 299462 [TBL] [Abstract][Full Text] [Related]
10. Cervicovaginal fistula: an apparent increased incidence with prostaglandin F2alpha. Lowensohn R; Ballard C Am J Obstet Gynecol; 1974 Aug; 119(8):1057-61. PubMed ID: 4847442 [TBL] [Abstract][Full Text] [Related]
12. The effects of longacting paracervical block anesthesia on the abortifacient efficacy of intra-amniotic PGF2alpha and hypertonic saline. Ragab MI; Edelman DA; Laufe L Acta Obstet Gynecol Scand; 1978; 57(4):327-31. PubMed ID: 358727 [TBL] [Abstract][Full Text] [Related]
13. Midtrimester abortion using prostaglandin F2alpha, oxytocin, and laminaria. Engel T; Greer B; Kochenour N; Droegemueller W Fertil Steril; 1973 Aug; 24(8):565-8. PubMed ID: 4718913 [TBL] [Abstract][Full Text] [Related]
14. Prostaglandin F2 alpha, oxytocin, and uterine activation in hypertonic saline-induced abortions. Fuchs AR; Rasmussen AB; Rehnström J; Toth M Am J Obstet Gynecol; 1984 Sep; 150(1):27-32. PubMed ID: 6476024 [TBL] [Abstract][Full Text] [Related]
15. Urea-prostaglandin versus hypertonic saline for instillation abortion. Binkin NJ; Schulz KF; Grimes DA; Cates W Am J Obstet Gynecol; 1983 Aug; 146(8):947-52. PubMed ID: 6576633 [TBL] [Abstract][Full Text] [Related]
16. Intra-amniotic prostaglandin F2alpha and urea for midtrimester abortion. Wellman L; Jacobson A Fertil Steril; 1976 Dec; 27(12):1374-9. PubMed ID: 1001522 [TBL] [Abstract][Full Text] [Related]
17. The effect of a 10 cm2, 0.5% 15-ME-PGF2alpha methyl ester intravaginal silastic device on abortion and plasma prostaglandin concentration. Lauersen NH; Wilson KH Prostaglandins; 1977 Apr; 13(4):755-62. PubMed ID: 857275 [TBL] [Abstract][Full Text] [Related]